ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
2
3
Scope of analysisNotes
4
5
Unit of analysis (full organization or program of a larger organization)Malaria Consortium's SMC program
6
Analysis 'as of' dateJune 30, 2018
7
8
9
10
Funds on handAmountNotes
11
12
Funds in the bank for Malaria Consortium's SMC program as of June 30, 2018$26,899,250
13
Of funds in the bank for Malaria Consortium's SMC program, amount committed to future activities$26,448,510
15
Uncommitted, unreserved funds in the bank$450,740
16
17
18
19
Projected revenueValue from same period in previous yearAre there any reasons why last year's revenue is not a reasonable projection for next year (ignoring variation in GiveWell-influenced funding)?Projection (before GiveWell's 2018 recommendation)Notes
22
Projected revenue from donors who are not influenced by GiveWell's research in most recent fiscal year (or another annual period consistent with the above)--$0Malaria Consortium's only sources of funding for the SMC program in the last few years has been GiveWell-directed funds and the ACCESS-SMC project, which has now ended.
23
Funding held by GiveWell as of the end of most recent fiscal year (or another annual period consistent with the above)--$24,432From GiveWell's internal donation records.
24
Annual projected revenue from donors who give based on GiveWell's top charity list, but do not follow our recommendation for marginal funding--$1,129,848GiveWell maintains both a list of all top charities that meet our criteria and a recommendation for which charity or charities to give to to maximize the impact of additional donations, given cost-effectiveness of remaining funding gaps.

Estimate based on amont of funding we tracked to Malaria Consortium based on our recommendation in our 2017 metrics year. Excludes grants that we recommended Good Ventures make to Malaria Consortium.
25
[For programs that are part of a larger org] Funding expected for the program from parent organization's unrestricted funding$0-Malaria Consortium told us that it does not have unrestricted funding available for significant allocations to programs.
26
27
28
29
Bottom line
30
31
'Baseline' funding pot for Malaria Consortium's SMC program$1,605,020
32
Revenue projection for second year$0
33
Revenue projection for third year$0
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103